Tag Archives: Wellcome Trust
Kolkata (IANS): Paving the way for personalised medicine, Indian scientists have identified for the first time various genetic alterations found in prostate cancer patients in the country, a development that could aid clinicians diagnose, decide and select the most effective and precise therapy for the person.
London: Resistance to the antimalarial drug artemisinin is established in Myanmar and has reached within 25 km of the Indian border. Artemisinin resistance threatens to follow the same historical trajectory from South-east Asia to the Indian subcontinent seen in the past with other antimalarial medicines.
Picture this. You are a doctor who thoroughly enjoys treating his patients but somewhere yearns to innovate something that can make diagnosis and treatment easier as well as improve the lives of his patients.
London: A University of Cambridge study questions previous suggestions that attention deficit hyperactivity disorder (ADHD) is the result of fundamental abnormalities in dopamine transmission, and suggests that the main cause of the disorder may lie instead in structural differences in the grey matter in the brain.
Toronto: A research team of The Research Institute of the McGill University Health Centre (RI-MUHC) has received the 2013 Accelerating Science Award Programme (ASAP). The team, led by Dr Nitika Pant Pai, won the recognition for developing an innovative self-test screening strategy for the human immunodeficiency virus (HIV).
London: A new gene associated with a form of congenital heart disease in newborn babies – known as “a hole in the heart” – has been discovered by researchers.
London: A drug widely used to treat Parkinson’s disease can help to reverse age-related impairments indecision making in some older people, a study from researchers at the Wellcome Trust Centre for Neuroimaging has shown.
Sydney: An international collaboration including researchers from Telethon Institute for Child Health Research and Banaras Hindu University (BHU) has identified a critical genetic risk factor for a potentially fatal parasitic disease that affects up to 400,000 people a year, mostly children.
London: Scientists have discovered a patient-friendly and efficient way to make stem cells out of blood, increasing the hope that scientists could one day use stem cells made from patients’ own cells to treat cardiovascular disease. Their research is published in the journal Stem Cells: Translational Medicine.